Application of CDK4/6 Inhibitors in Premenopausal Women with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: a Real-World Experience

被引：0
|
作者：
Kurbacher, Christian M. [1 ]
Fischer, Lotta Ada [2 ]
Heinrich, Georg [3 ]
Herz, Susanne [1 ]
Schott, Alexander [1 ]
Kurbacher, A. Tabea [1 ]
Kurbacher, Jutta Anna [4 ]
Rudlowski, Christian [5 ]
Warm, Mathias R. [2 ]
机构：
[1] Gynakol Zentrum Bonn Friedenspl, Gynakol Schwerpunkt Gynakol Onkol 1, Bonn, Germany
[2] Stadt Klinikum Holweide, Brustzentrum, Cologne, Germany
[3] Praxis Gynakol Onkol, Furstenwalde, Germany
[4] Gynakol Zentrum Bonn Friedenspl, Gynakol Allgemeine Gynakol & Geburtshilfe 2, Bonn, Germany
[5] Evangel Krankenhaus Bergisch Gladbach, Frauenklin, Bergisch Gladbach, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
552
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
    Messina, Carlo
    Cattrini, Carlo
    Buzzatti, Giulia
    Cerbone, Luigi
    Zanardi, Elisa
    Messina, Marco
    Boccardo, Francesco
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (01) : 9 - 21
  • [32] ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
    Matikas, A.
    Lambertini, M.
    ESMO OPEN, 2021, 6 (01)
  • [33] Real-world experience with CDK4/6 inhibitors for HR+/HER2-metastatic breast cancer (MBC)
    Abdallah, H. M. A.
    Owoseni, Y. I.
    Sultan, A.
    Ahmed, S.
    Wood, J.
    Varadhan, B.
    Ayodele, O.
    ANNALS OF ONCOLOGY, 2023, 34 : S369 - S370
  • [34] Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer
    Bayraktar, Soley
    Batoo, Sameer
    Al-Hattab, Eyad
    Basu, Sandeep
    Okuno, Scott
    Gluck, Stefan
    FUTURE ONCOLOGY, 2020, 16 (32) : 2661 - 2672
  • [35] CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge
    de Melo Gagliato, Debora
    Buzaid, Antonio C.
    Manuel Perez-Garcia, Jose
    Llombart, Antonio
    Cortes, Javier
    CANCERS, 2020, 12 (09) : 1 - 19
  • [36] Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience
    Decker, Thomas
    Seifert, Robert
    Bichler, Matthias
    Birtel, Andrea
    Fischer, Gerhard
    Nonnenbroich, Christoph
    Dechow, Tobias
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (09) : 443 - 448
  • [37] Real-World Experience with CDK4/6 Inhibitors for Metastatic HR +/HER2-Breast Cancer at a Single Cancer Center
    Kovacevic, M. Milovic
    Bobic, S.
    Karaferic, A.
    Pavlovic, L.
    Matovic, M.
    BREAST, 2023, 68 : S46 - S46
  • [38] Results from a real-world study of patients (pts) with hormone-receptor (HR)-positive HER2-negative metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK 4/6i) in three institutions
    Pla, H.
    Recalde Penabad, S.
    Vinas Villaro, G.
    Margeli Vila, M.
    Obadia Gil, V. L.
    Cirauqui Cirauqui, B.
    Del Barco Berron, S.
    J. Gil, M.
    Quiroga Garcia, V.
    Teruel-Garcia, I.
    Pernas Simon, S.
    Stradella, A.
    Esteve Gomez, A. M.
    Felip, E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S660 - S660
  • [39] Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor-positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities
    Lloyd, Maxwell R.
    Spring, Laura M.
    Bardia, Aditya
    Wander, Seth A.
    CLINICAL CANCER RESEARCH, 2022, 28 (05) : 821 - 830
  • [40] Abemaciclib and endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: A real-world UK multicentre experience
    Battisti, Nicolo Matteo Luca
    Morrison, Laura
    Nash, Tamsin
    Senthivel, Nishanti
    Kestenbaum, Samantha
    Begum, Parvin
    Obeid, Mariam
    Hayhurst, William
    Yang, Dorothy
    Gafoor, Shafiah
    Brown, Caroline
    Rehman, Farah
    Kenny, Laura
    Hatcher, Olivia
    Susan, Susan
    Williams, Jennet
    Brown, Anna
    Rozati, Hamoun
    Alexandros, Alexandros
    Sawyer, Elinor
    Gousis, Charalampos
    Karapanagiotou, Eleni
    Rigg, Anna
    Rapti, Kleopatra
    Roylance, Rebecca
    Beresford, Mark
    Gee, Abigail L.
    Konstantis, Apostolos
    King, Judy
    Nathan, Mark
    Spurrell, Emma
    Pearce, Mark
    Bradwell, Dane
    Denton, Arshi
    Swain, Kate
    McGrath, Sophie
    Allen, Mark
    Ring, Alistair
    Johnston, Stephen
    Raja, Fharat
    CANCER RESEARCH, 2022, 82 (04)
12345